V131=
SynonymousSilentLikely benignCytoplasmic · predictedSilent — Silent — no amino-acid change
Interactive 3D Structure
AlphaFold wild-type wolframin · the variant site near residue 131 (N-terminal cytoplasmic (intrinsically disordered)) is highlighted.
Variant Assessment
Therapeutic Implication · Silent
Clinical Evidence
Observed at very low frequency in gnomAD.
Feed this card to Wolfram Intelligence
Download the V131= card below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals matched to this Silent synonymous variant and its domain context.
Full Variant Card
V131= — WFS1 Molecular Atlas Card
Variant type: Synonymous (silent) Codon: position 131 (Valine, V) — amino acid unchanged Domain context: N-terminal cytoplasmic (intrinsically disordered)
Schema category: Silent — Silent — no amino-acid change
No amino-acid change (V131 is unchanged): the codon is altered but the protein sequence is identical to wild-type. No structural, stability or AlphaMissense effect applies. Synonymous variants are typically benign unless they affect splicing or regulatory elements; this one is not adjacent to an exon boundary.
Clinical evidence
- Classification: Likely benign
- Review status: criteria provided, multiple submitters, no conflicts
- Associated conditions: Cataract 41; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome; Wolfram syndrome 1
- cDNA change: c.393C>T
- ClinVar accession: VCV001207388
- Last evaluated: 2025/12/03 00:00
- Submissions: 1
Card generated by wolfram-atlas-batch (synonymous pipeline) on 2026-06-08T02:51:00.008089Z.
WFS1: UniProt O76024, AlphaFold v6. Synonymous variants carry no protein-structural effect.